A previous study has shown that EMP3 is hypermethylated in approximately 20–40% of neuroblastoma and glioma cases, and plays a role in tumor suppression, which is also related with patients’ prognosis [26]. The gene discussed is EMP3; the disease is central nervous system cancer.